← Leaderboards
Rachel S Knipe
Massachusetts General Hospital
$3,383,151
Attributed
$3,529,290
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,529,290 · 4
By mechanism
R01$2,206,371 · 1
K08$864,000 · 1
R41$292,279 · 1
R03$166,640 · 1
Top collaborators
- Robert N Willette1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Allan M Goldstein$7,045,731
- Vijaya Ramesh$9,458,883
- David Mischoulon$2,655,362
- Peter D Caravan$27,832,958
- Sydney Montesi$2,223,234
Others in their field
Other Emerging Leaders on “Injury”
- Ashlee Fitch · Steelworker Charitable/Educational Org$14,396,687
- Manish Ishwar Shah · Baylor College Of Medicine$13,280,421
- Bryan L McLaughlin · Micro-Leads, Inc.$11,933,203
- Sharon Dziuba Yeatts · University Of Michigan At Ann Arbor$11,654,686
- Vera Hoffman · Reveal Pharma$10,532,099
- Rajni Samavedam · Booz Allen Hamilton$9,935,296
Research focus
InjuryEndothelial CellsBlood VesselsMouse ModelPulmonary FibrosisSignal TransductionMediatingPreventAttenuatedMortalityVascular PermeabilitiesRepairedLungFibrosisLung InjuryLeadBleomycinRespiratory FailureGeneticNew Therapeutic TargetEndotheliumFibroblastsNovel TherapeuticsChronic
Grant awards (11)
Loss of Endothelial S1PR1 Drives Post-Influenza Pulmonary Fibrosis$737,205
R01 · FY2025 · HL · contact PI
Validation of APT101 for the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) in an Aging Murine Model$292,279
R41 · FY2025 · AG
Loss of Endothelial S1PR1 Drives Post-Influenza Pulmonary Fibrosis$729,408
R01 · FY2024 · HL · contact PI
Loss of Endothelial S1PR1 Drives Post-Influenza Pulmonary Fibrosis$739,758
R01 · FY2023 · HL · contact PI
Histologic and Transcriptional Profiling of Endothelial Cells During Progressive Pulmonary Fibrosis$83,320
R03 · FY2023 · HL · contact PI
Role and regulation of vascular permeability in pulmonary fibrosis$172,800
K08 · FY2022 · HL · contact PI
Histologic and Transcriptional Profiling of Endothelial Cells During Progressive Pulmonary Fibrosis$83,320
R03 · FY2022 · HL · contact PI
Role and regulation of vascular permeability in pulmonary fibrosis$172,800
K08 · FY2021 · HL · contact PI
Role and regulation of vascular permeability in pulmonary fibrosis$172,800
K08 · FY2020 · HL · contact PI
Role and regulation of vascular permeability in pulmonary fibrosis$172,800
K08 · FY2019 · HL · contact PI
Role and regulation of vascular permeability in pulmonary fibrosis$172,800
K08 · FY2018 · HL · contact PI